Urologische Klinik und Poliklinik » Forschung » Publikationen 2020

Publikationen 2020

Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.
Am J Cancer Res 2020; 10(11): 3784-3800;
Wang L, Stadlbauer B, Lyu C, Buchner A, Pohla H

Heteroresistant Bacteria Detected by an Extended Raman-based Antibiotic Susceptibility Test.
Anal Chem 2020;92(13): 8722-8731
Bauer D, Wieland K, Qiu L, Neumann-Cip AC, Magistro G, Stief CG, Wieser A, Haisch C

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma.
Andrologia 2020;
Marcon J, Trottmann M, Rodler S, Becker AJ, Stief CG, Bauer RM, Casuscelli J

Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
BJU Int 2020; 126(4): 509-519;
Gakis G, Karl A, Bertz S, Burger M, Fritsche HM, Hartmann A, Jokisch F, Kempkensteffen C, Miller K, Mundhenk J, Schneevoigt BS, Schubert T, Schwentner C, Wullich B, Stenzl A

Regulation of smooth muscle contraction by monomeric non-RhoA GTPases.
Br J Pharmacol 2020;
Li B, Wang R, Wang Y, Stief CG, Hennenberg M

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
Cancers 2020; 12(5);
Shi R, Bao X, Rogowski P, Schäfer C, Schmidt-Hegemann NS, Unger K, Lu S, Sun J, Buchner A, Stief C, Belka C, Li M

Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI-CEUS) in Oncology.
Cancers (Basel) 2020; 12(10)
Schwarze V, Rübenthaler J, Marschner C, Fabritius MP, Rueckel J, Fink N, Puhr-Westerheide D, Gresser E, Froelich MF, Schnitzer ML, Große Hokamp N, Afat S, Staehler M, Geyer T, Clevert DA

Contrast-Enhanced Ultrasound (CEUS) for Follow-Up of Bosniak 2F Complex Renal Cystic Lesions-A 12-Year Retrospective Study in a Specialized European Center.
Cancers (Basel) 2020; 12(8)
Rübenthaler J, Čečatka S, Froelich MF, Stechele M, Marschner C, Sabel BO, Bogner F, Schnitzer ML, Overhoff D, Große Hokamp N, Staehler M, Schwarze V, Clevert DA

Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis.
Cancers (Basel) 2020; 12(11)
Schmidt Hegemann NS, Rogowski P, Eze C, Schäfer C, Stief C, Lang S, Spohn S, Steffens R, Li M, Gratzke C, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Ganswindt U, Buchner A, Grosu AL, Belka C, Meyer PT, Kirste S, Zamboglou C

Total Penectomy for Recurrent Chordoma of the Corpus Cavernosum.
Case Rep Urol 2020;
Eismann L, Kess S, Stief CG, Strittmatter F

Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
Cell Oncol (Dordr) 2020;
Schnitzler T, Ortiz-Brüchle N, Schneider U, Lurje I, Guricova K, Buchner A, Schulz GB, Heidenreich A, Gaisa NT, Knüchel R, Garczyk S

Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial.
Clin Cancer Res 2020; 26(18): 4863-4868;
Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ

Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
Clin Genitourin Cancer 2020; 18(3): 162-170.e4;
Schulz GB, Grimm T, Buchner A, Jokisch F, Kretschmer A, Stief CG, Knüchel R, Kraywinkel K, Karl A

Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study.
Clin Genitourin Cancer 2020;
Erlmeier F, Steffens S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Ivanyi P, (German Network Of Kidney Cancer)

Patients' Perspective on Digital Technologies in Advanced Genitourinary Cancers.
Clin Genitourin Cancer 2020;
Rodler S, Buchner A, Stief CG, Heinemann V, Staehler M, Casuscelli J

Predictive clinical features for negative histopathology of MRI/ Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
Clin Hemorheol Microcirc 2020;
Apfelbeck M, Pfitzinger P, Bischoff R, Rath L, Buchner A, Mumm JN, Schlenker B, Stief CG, Chaloupka M, Clevert DA

Prospective evaluation of 4-D contrast-enhanced-ultrasound (CEUS) imaging in bladder tumors.
Clin Hemorheol Microcirc 2020; 74(1): 1-12;
Jokisch F, Buchner A, Schulz GB, Grimm T, Weinhold P, Pfitzinger PL, Chaloupka M, Stief CG, Schlenker B, Clevert DA

Lessons from the coronavirus disease 2019 pandemic: Will virtual patient management reshape uro-oncology in Germany?
Eur J Cancer 2020; 132(): 136-140;
Rodler S, Apfelbeck M, Stief C, Heinemann V, Casuscelli J

Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission.
Eur J Clin Pharmacol 2020;
Seiberth S, Bauer D, Schönermarck U, Mannell H, Stief C, Hasford J, Strobach D

18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
Eur J Nucl Med Mol Imaging 2020;
Mittlmeier LM, Unterrainer M, Rodler S, Todica A, Albert NL, Burgard C, Cyran CC, Kunz WG, Ricke J, Bartenstein P, Stief CG, Ilhan H, Staehler M

PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma.
Eur J Nucl Med Mol Imaging 2020;
Mittlmeier LM, Unterrainer M, Todica A, Cyran CC, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M

Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers.
Eur J Pharmacol 2020;
Wang X, Li B, Ciotkowska A, Rutz B, Erlander MG, Ridinger M, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.
Eur Radiol 2020; 30(1): 1-10;
Marcon J, Graser A, Horst D, Casuscelli J, Spek A, Stief CG, Reiser MF, Rübenthaler J, Buchner A, Staehler M

Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series.
Eur Urol 2020;
Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A

External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection.
Eur Urol 2020; 78(2): 138-142;
Gandaglia G, Martini A, Ploussard G, Fossati N, Stabile A, De Visschere P, Borgmann H, Heidegger I, Steinkohl F, Kretschmer A, Marra G, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, Van den Bergh R, Ost P, Gontero P, Montorsi F, Briganti A, EAU-YAU Prostate Cancer Working Group

Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.
Eur Urol 2020;
Bravi CA, Fossati N, Gandaglia G, Suardi N, Mazzone E, Robesti D, Osmonov D, Juenemann KP, Boeri L, Jeffrey Karnes R, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A

Pretreatment Risk Stratification Tools for Prostate Cancer-Moving from Good to Better, Toward the Best.
Eur Urol 2020; 77(2): 189-190;
Herlemann A

Re: Clinical Efficacy and Biomarker Analysis of Neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the ABACUS Trial.
Eur Urol 2020;
Schulz GB, Black PC

Re: Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy Versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.
Eur Urol 2020;
Wirth M, Stief C, Stenzl A

The New Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting Database: Opportunities and Limitations.
Eur Urol 2020;
Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR

Urinary Frequency as a Possibly Overlooked Symptom in COVID-19 Patients: Does SARS-CoV-2 Cause Viral Cystitis?
Eur Urol 2020;
Mumm JN, Osterman A, Ruzicka M, Stihl C, Vilsmaier T, Munker D, Khatamzas E, Giessen-Jung C, Stief C, Staehler M, Rodler S

Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma.
Eur Urol Focus 2020;
Staehler M, Battle D, Pal SK, Bergerot CD

Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review.
Eur Urol Focus 2020;
Kretschmer A, Ploussard G, Heidegger I, Tsaur I, Borgmann H, Surcel C, Mathieu R, de Visschere P, Valerio M, van den Bergh RCN, Marra G, Thibault C, Ost P, Gandaglia G, Tilki D, EAU-YAU Prostate Cancer Working Party

How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound?
Eur Urol Focus 2020;
Herlemann A, Overland MR, Washington SL, Cowan JE, Westphalen AC, Carroll PR, Nguyen HG, Shinohara K, Cooperberg MR

Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.
Eur Urol Focus 2020;
Kretschmer A, Mazzone E, Barletta F, Leni R, Heidegger I, Tsaur I, van den Bergh RCN, Valerio M, Marra G, Kasivisvanathan V, Buchner A, Stief CG, Briganti A, Montorsi F, Tilki D, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.
Eur Urol Focus 2020; 6(4): 704-710;
Kretschmer A, Grimm T, Buchner A, Jokisch F, Ziegelmüller B, Casuscelli J, Schulz G, Stief CG, Karl A

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
Eur Urol Focus 2020; 6(5): 1097-1103;
Rodler S, Apfelbeck M, Schulz GB, Ivanova T, Buchner A, Staehler M, Heinemann V, Stief C, Casuscelli J

Treatment of Metastasized Prostate Cancer Beyond Progression After Upfront Docetaxel-A Real-world Data Assessment.
Eur Urol Focus 2020;
Tsaur I, Heidegger I, van den Bergh RCN, Bektic J, Borgmann H, Foti S, Hunting JCB, Kretschmer A, Ploussard G, Tilki D, Gandaglia G, Dotzauer R, EAU-YAU Prostate Cancer Working Party

A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Eur Urol Oncol 2020;
Heidegger I, Necchi A, Pircher A, Tsaur I, Marra G, Kasivisvanathan V, Kretschmer A, Mathieu R, Ceci F, van den Bergh RCN, Thibault C, Tilki D, Valerio M, Surcel C, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data.
Eur Urol Oncol 2020;
de Bruijn R, Wimalasingham A, Szabados B, Stewart GD, Welsh SJ, Kuusk T, Blank C, Haanen J, Klatte T, Staehler M, Powles T, Bex A

Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.
Eur Urol Oncol 2020; 3(4): 433-452;
Abu-Ghanem Y, Fernández-Pello S, Bex A, Ljungberg B, Albiges L, Dabestani S, Giles RH, Hofmann F, Hora M, Kuczyk MA, Kuusk T, Marconi L, Merseburger AS, Tahbaz R, Staehler M, Volpe A, Powles T, Lam TB, Bensalah K

Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
Eur Urol Oncol 2020; 3(5): 565-581;
Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F, Ploussard G, van den Bergh RCN, Kretschmer A, Thibault C, Ost P, Tilki D, Kasivisvanathan V, Moschini M, Sanchez-Salas R, Gontero P, Karnes RJ, Montorsi F, Gandaglia G, EAU-YAU Prostate Cancer Working Party

Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.
Eur Urol Oncol 2020; 3(1): 57-72;
Fernandéz-Pello S, Hora M, Kuusk T, Tahbaz R, Dabestani S, Abu-Ghanem Y, Albiges L, Giles RH, Hofmann F, Kuczyk MA, Lam TB, Marconi L, Merseburger AS, Powles T, Staehler M, Volpe A, Ljungberg B, Bex A, Bensalah K

The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy.
Eur Urol Oncol 2020; 3(1): 47-56;
DiNatale RG, Xie W, Becerra MF, Silagy AW, Attalla K, Sanchez A, Mano R, Marcon J, Blum KA, Benfante NE, Voss MH, Motzer RJ, Coleman J, Choueiri TK, Reznik E, Russo P, Heng DYC, Hakimi AA

Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766.
Front Pharmacol 2020;
Li B, Yu Q, Wang R, Gratzke C, Wang X, Spek A, Herlemann A, Tamalunas A, Strittmatter F, Waidelich R, Stief CG, Hennenberg M

Exploratory analysis of the platelet-to-lymphocyte ratio prognostic value in the adjuvant renal cell cancer setting.
Future Oncol 2020;
Patel A, Ravaud A, Motzer RJ, Pantuck AJ, Staehler M, Escudier B, Martini JF, Lechuga M, Lin X, George DJ

[Diagnosis and treatment of syphilis : Update of the S2k guidelines 2020 of the German STI Society (DSTIG) in cooperation with the following specialist societies: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI].
Hautarzt 2020; 71(12): 969-999;
Schöfer H, Enders M, Esser S, Feiterna-Sperling C, Hagedorn HJ, Magistro G, Mayr C, Münstermann D, Hahn K, Jansen K, Klein M, Krause W, Maschke M, Ochsendorf FR, Osowski S, Petry KU, Potthoff A, Rieg S, Sing A, Stücker M, Weberschock T, Werner RN, Brockmeyer NH

Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics.
Infection 2020;
Westhofen T, Magistro G, Lennartz S, Casuscelli J, Stief C, Rodler S

The impact of perioperative complications on favorable outcomes after artificial urinary sphincter implantation for post-prostatectomy incontinence.
Int Braz J Urol 2020; 46(4): 632-639;
Kretschmer A, Hüsch T, Anding R, Pottek T, Rose A, Struss W, Queissert F, Naumann CM, Nyarangi-Dix JN, Brehmer B, Haferkamp A, Bauer RM, Debates On Male Incontinence (DOMINO)-Project

Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma: Final results of the MARC-2 trial.
Int J Cancer 2020;
Staehler M, Stöckle M, Christoph DC, Stenzl A, Potthoff K, Grimm MO, Klein D, Harde J, Brüning F, Goebell PJ, Augustin M, Roos F, Benz-Rüd I, Marschner N, Grünwald V

Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Int J Cancer 2020; 146(7): 2036-2046;
Gerke JS, Orth MF, Tolkach Y, Romero-Pérez L, Wehweck FS, Stein S, Musa J, Knott MML, Hölting TLB, Li J, Sannino G, Marchetto A, Ohmura S, Cidre-Aranaz F, Müller-Nurasyid M, Strauch K, Stief C, Kristiansen G, Kirchner T, Buchner A, Grünewald TGP

Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
Int J Cancer 2020; 146(5): 1307-1315;
Staehler M, Goebell PJ, Müller L, Emde TO, Wetzel N, Kruggel L, Jänicke M, Marschner N, RCC-Registry Group (Tumour Registry of Advanced Renal Cell Carcinoma)

External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol 2020; 25(1): 145-150;
Zastrow S, Krabbe LM, Wolff I, Capitanio U, Klatte T, Ecke T, Huck N, Borgmann H, Scavuzzo A, Cindolo L, Schips L, Surcel C, Mirvald C, Cabo AV, Musquera M, Hutterer G, Procházková K, Stief C, Wirth M, May M, Brookman-May S

EP3 Is an Independent Prognostic Marker Only for Unifocal Breast Cancer Cases.
Int J Mol Sci 2020; 21(12)
Zati Zehni A, Jeschke U, Hester A, Kolben T, Ditsch N, Jacob SN, Mumm JN, Heidegger HH, Mahner S, Vilsmaier T

Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Int J Radiat Oncol Biol Phys 2020;
Siva S, Correa RJM, Warner A, Staehler M, Ellis RJ, Ponsky L, Kaplan ID, Mahadevan A, Chu W, Gandhidasan S, Swaminath A, Onishi H, Teh BS, Lo SS, Muacevic A, Louie AV

Influence of the laser pulse shape in the treatment of stones in the upper urinary tract.
Investig Clin Urol 2020; 61(6): 594-599;
Alghamdi A, Kretschmer A, Stief CG, Strittmatter F

Open ureteroplasty with buccal mucosa graft for long proximal strictures: A good option for a rare problem.
Investig Clin Urol 2020; 61(3): 316-322;
Hefermehl LJ, Tritschler S, Kretschmer A, Beck V, Stief CG, Schlenker B, Strittmatter F

Superiority of HoLEP over TURP in a matched-pair analysis of bleeding complications under various antithrombotic regimens.
J Endourol 2020;
Westhofen T, Schott M, Keller P, Tamalunas A, Stief C, Magistro G

Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers.
J Geriatr Oncol 2020;
Schulz GB, Rodler S, Szabados B, Graser A, Buchner A, Stief C, Casuscelli J

First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T in advanced mCRPC patients.
J Nucl Med 2020;
Zacherl MJ, Gildehaus FJ, Mittlmeier L, Boening G, Gosewisch A, Wenter V, Schmidt-Hegemann NS, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H

Editorial Comment.
J Urol 2020; 204(3)
Kretschmer A

Reply by Authors.
J Urol 2020;
Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrien A, Galosi AB, Montorsi F, Briganti A

Underestimation of PET/CT Scan in Assessing Tumour Burden of Men With Nodal Recurrence From Prostate Cancer: Head-to-Head Comparison OF 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.
J Urol 2020;
Fossati N, Scarcella S, Gandaglia G, Suardi N, Robesti D, Boeri L, Karnes RJ, Heidenreich A, Pfister D, Kretschmer A, Buchner A, Stief C, Battaglia A, Joniau S, Van Poppel H, Osmonov D, Juenemann KP, Shariat S, Hiester A, Nini A, Albers P, Tilki D, Graefen M, Gill IS, Mottrie A, Galosi AB, Montorsi F, Briganti A

[Digital innovation in medicine: the COVID-19 pandemic as an accelerator of "digital health"].
J Urol Urogynakologie 2020; (): 1-5;
Mumm JN, Rodler S, Mumm ML, Bauer RM, Stief CG

Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US.
JAMA Netw Open 2020; 3(12)
Washington SL, Jeong CW, Lonergan PE, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma.
JCO Oncol Pract 2020; 16(11): e1264-e1271;
Bergerot CD, Battle D, Philip EJ, Bergerot PG, Msaouel P, Smith A', Bamgboje AE, Shuch B, Derweesh IH, Jonasch E, Stern AP, Pal SK, Staehler M

The Relative Impact of Urinary and Sexual Function vs Bother on Health Utility for Men With Prostate Cancer.
JNCI Cancer Spectr 2020; 4(5)
Jeong CW, Herlemann A, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR

Surgery for benign prostatic obstruction.
Lancet 2020; 396(10243): 5-7;
Magistro G, Stief CG

Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells.
Life Sci 2020; 261()
Wang R, Yu Q, Wang X, Li B, Ciotkowska A, Rutz B, Wang Y, Stief CG, Hennenberg M

A matched-pair analysis of patients with medium-sized prostates (50 cc) treated for male LUTS with HoLEP or TURP.
Low Urin Tract Symptoms 2020; 12(2): 117-122;
Magistro G, Westhofen T, Stief CG, Weinhold P

The clinical value of holmium laser enucleation of the prostate in octogenarians.
Low Urin Tract Symptoms 2020;
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G

Harnwegsinfekt: kompliziert oder unkompliziert? : Urologie.
MMW Fortschr Med 2020; 162(16): 40-43;
Volz Y, Eismann L, Stief CG, Magistro G

Hodenhochstand: Ist die Fertilität in Gefahr? : Urologie -- Autoren: R. J. F. Stredele, P. Keller, M. Mainusch, K. Lellig, M. Apfelbeck, M. Riccabona, C.G. Stief, J. Marcon.
MMW Fortschr Med 2020; 162(18): 48-49;
Stredele RJF, Keller P, Mainusch M, Lellig K, Apfelbeck M, Riccabona M, Stief CG, Marcon J

Häufige urologische Infektionen und der viel diskutierte PSA-Wert.
MMW Fortschr Med 2020; 162(16)
Stief CG

Management der Prostatitis und bakteriellen Epididymitis : Urologie.
MMW Fortschr Med 2020; 162(16): 48-53;
Eismann L, Volz Y, Stief C, Magistro G

PSA-Test: Sinn oder Unsinn? : Urologie.
MMW Fortschr Med 2020; 162(16): 44-47;
Chaloupka M, Kretschmer A, Stief CG, Apfelbeck M

Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Bosniak III Complex Renal Cystic Lesions-A 10-Year Specialized European Single-Center Experience with Histopathological Validation.
Medicina (Kaunas) 2020; 56(12)
Schwarze V, Rübenthaler J, Čečatka S, Marschner C, Froelich MF, Sabel BO, Staehler M, Knösel T, Geyer T, Clevert DA

How do elevated levels of testosterone affect the function of the human fallopian tube and fertility?-New insights.
Mol Reprod Dev 2020; 87(1): 30-44;
Dulohery K, Trottmann M, Bour S, Liedl B, Alba-Alejandre I, Reese S, Hughes B, Stief CG, Kölle S

The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor.
Naunyn Schmiedebergs Arch Pharmacol 2020; 393(5): 829-842;
Li B, Wang X, Rutz B, Wang R, Tamalunas A, Strittmatter F, Waidelich R, Stief CG, Hennenberg M

Comprehensive analysis of Twitter activity on #Incontinence.
Neurourol Urodyn 2020; 39(1): 440-446;
Grabbert M, Khoder WY, Gratzke C, Paffenholz P, Salem J, Bauer RM

High/low-volume center experience predicts outcome of AMS 800 in male stress incontinence: Results of a large middle European multicenter case series.
Neurourol Urodyn 2020; 39(6): 1856-1861;
Queissert F, Hüsch T, Kretschmer A, Anding R, Kirschner-Hermanns R, Pottek T, Olianas R, Friedl A, Homberg R, Pfitzenmaier J, Naumann CM, Nyarangi-Dix J, Hofmann T, Rose A, Schweiger J, Hübner W, Loertzer H, Bauer RM, Haferkamp A, Schrader AJ, Debates On Male Incontinence (DOMINO)-Project

Retropubic vs transobturator Argus adjustable male sling: Results from a multicenter study.
Neurourol Urodyn 2020; 39(3):987-993
Loertzer H, Huesch T, Kirschner-Hermanns R, Anding R, Rose A, Brehmer B, Naumann CM, Queissert F, Nyarangi-Dix J, Homberg R, Grabbert M, Hofmann T, Pottek T, Hübner W, Haferkamp A, Bauer RM, Kretschmer A

The transient receptor potential A1 ion channel (TRPA1) modifies in vivo autonomous ureter peristalsis in rats.
Neurourol Urodyn 2020;
Weinhold P, Villa L, Strittmatter F, Gratzke C, Stief CG, Castiglione F, Montorsi F, Hedlund P

Fluorescence and Treatment Light Monitoring for Interstitial Photodynamic Therapy.
Photochem Photobiol 2020; 96(2): 388-396;
Heckl C, Aumiller M, Rühm A, Sroka R, Stepp H

Evaluation of lensed fibers used in photodynamic therapy (PDT).
Photodiagnosis Photodyn Ther 2020; 31()
Zou J, Li W, Men N, Jiang J, Wu C, Lei TC, Sroka R, Huang Z

MOP-dependent enhancement of methadone on the effectiveness of ALA-PDT for A172 cells by upregulating phosphorylated JNK and BCL2.
Photodiagnosis Photodyn Ther 2020;
Shi L, Pohla H, Buchner A, Zhang L, Pongratz T, Rühm A, Zimmermann W, Gederaas OA, Wang X, Stepp H, Sroka R

Inhibition of neurogenic and thromboxane A2 -induced human prostate smooth muscle contraction by the integrin α2β1 inhibitor BTT-3033 and the integrin-linked kinase inhibitor Cpd22.
Prostate 2020; 80(11): 831-849;
Li B, Wang X, Wang R, Rutz B, Ciotkowska A, Gratzke C, Herlemann A, Spek A, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillance.
Prostate Cancer Prostatic Dis 2020; 23(1): 136-143;
Herlemann A, Huang HC, Alam R, Tosoian JJ, Kim HL, Klein EA, Simko JP, Chan JM, Lane BR, Davis JW, Davicioni E, Feng FY, McCue P, Kim H, Den RB, Bismar TA, Carroll PR, Cooperberg MR

Multiparametric magnetic resonance imaging and multiparametric magnetic resonance imaging-guided biopsy in the diagnostic pathway of prostate cancer.
Radiologe 2020; 60(Suppl 1):63-69
Chaloupka M, Apfelbeck M, Pfitzinger P, Bischoff R, Lellig E, Rath L, Schlenker B, Stief CG, Clevert D

Multiparametric ultrasonographic analysis of testicular tumors: a single-center experience in a collective of 49 patients.
Scand J Urol 2020; 54(3): 241-247;
Schwarze V, Marschner C, Sabel B, de Figueiredo GN, Marcon J, Ingrisch M, Knösel T, Rübenthaler J, Clevert DA

Postoperative change in Gleason score of prostate cancer in fusion targeted biopsy: a matched pair analysis.
Scand J Urol 2020; (): 1-6;
Apfelbeck M, Tritschler S, Clevert DA, Buchner A, Chaloupka M, Kretschmer A, Herlemann A, Stief C, Schlenker B

Comparative investigation of reusable and single-use flexible endoscopes for urological interventions.
Sci Rep 2020; 10(1)
Eisel M, Strittmatter F, Ströbl S, Freymüller C, Pongratz T, Sroka R

Natural selection supports escape from concerted evolution of a recently duplicated CEACAM1 paralog in the ruminant CEA gene family.
Sci Rep 2020; 10(1)
Hänske J, Hammacher T, Grenkowitz F, Mansfeld M, Dau TH, Maksimov P, Friedrich C, Zimmermann W, Kammerer R

Epidemiology and Treatment Barriers of Patients With Erectile Dysfunction Using an Online Prescription Platform: A Cross-Sectional Study.
Sex Med 2020;
Rodler S, von Büren J, Buchner A, Stief C, Elkhanova K, Wülfing C, Jungmann S

Benefits and Limitations of Transurethral Resection of the Prostate Training With a Novel Virtual Reality Simulator.
Simul Healthc 2020; 15(1): 14-20;
Schulz GB, Grimm T, Kretschmer A, Stief CG, Jokisch F, Karl A

PSMA-positive nodal recurrence in prostate cancer : Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis.
Strahlenther Onkol 2020;
Schmidt-Hegemann NS, Buchner A, Eze C, Rogowski P, Schaefer C, Ilhan H, Li M, Fendler WP, Bartenstein P, Ganswindt U, Stief C, Belka C, Kretschmer A

Fixed or adjustable sling in the treatment of male stress urinary incontinence: results from a large cohort study.
Transl Androl Urol 2020; 9(3): 1099-1107;
Hüsch T, Kretschmer A, Obaje A, Kirschner-Hermanns R, Anding R, Pottek T, Rose A, Olianas R, Friedl A, Homberg R, Pfitzenmaier J, Abdunnur R, Queissert F, Naumann CM, Schweiger J, Wotzka C, Nyarangi-Dix J, Hofmann T, Ulm K, Hübner W, Bauer RM, Haferkamp A, Debates On Male Incontinence (DOMINO)-Project

Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
Urol Int 2020; (): 1-8;
Tamalunas A, Buchner A, Kretschmer A, Jokisch F, Schulz G, Eismann L, Stief CG, Grimm T

Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution.
Urol Int 2020;
Tamalunas A, Volz Y, Schlenker BA, Buchner A, Kretschmer A, Jokisch F, Rodler S, Schulz G, Eismann L, Pfitzinger P, Stief CG, Grimm T

Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study.
Urol Int 2020; 104(1-2): 55-61;
Ziegelmueller BK, Jokisch JF, Buchner A, Grimm T, Kretschmer A, Schulz GB, Stief C, Karl A

Patient Selection in Surgical Centers of Expertise in the Treatment of Patients with Moderate to Severe Male Urinary Stress Incontinence.
Urol Int 2020; 104(11-12): 902-907;
Grabbert M, Bauer RM, Hüsch T, Kretschmer A, Kirschner-Hermanns R, Anding R, Brehmer B, Naumann CM, Queissert F, Khoder WY, Gratzke C, Hofmann T, Haferkamp A, Huebner WA

Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
Urol Int 2020; 104(1-2): 36-41;
Jokisch JF, Grimm T, Buchner A, Kretschmer A, Weinhold P, Stief CG, Karl A, Schulz GB

Secondary Sling Implantation after Failure of Primary Surgical Treatment for Male Stress Urinary Incontinence: A Retrospective Study.
Urol Int 2020; 104(7-8): 625-630;
Grabbert M, Hüsch T, Kretschmer A, Kirschner-Hermanns R, Anding R, Brehmer B, Naumann CM, Queissert F, Loertzer H, Khoder W, Gratzke C, Hofmann T, Huebner W, Haferkamp A, Bauer RM

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort.
Urol Oncol 2020; 38(11): 853.e1-853.e7;
Mano R, Duzgol C, Ganat M, Goldman DA, Blum KA, Silagy AW, Walasek A, Sanchez A, DiNatale RG, Marcon J, Kashan M, Becerra MF, Benfante N, Coleman JA, Kattan MW, Russo P, Akin O, Ostrovnaya I, Hakimi AA

Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival.
Urol Oncol 2020;
Volz Y, Grimm T, Ormanns S, Eismann L, Pfitzinger PL, Jokisch JF, Schulz G, Casuscelli J, Schlenker B, Karl A, Stief CG, Kretschmer A

[Chronic prostatitis/chronic pelvic pain syndrome].
Urologe A 2020; 59(6): 739-748;
Magistro G, Stief CG, Wagenlehner FME

[Mentoring in urological postgraduate training : Use of a competence matrix for the evaluation of results].
Urologe A 2020;
Necknig U, Leyh H, Gernhold L, Waidelich R, V Ostau N, Kunisch R, Kiesewetter J, Weidenbusch M

[Practical skills training : How suitable is Peyton's four-step approach for residents in urology?]
Urologe A 2020;
Necknig U, Buchner A, Leyh H, Pycha A, Borowitz R, Eder E, Frei C, Keller S, von Ostau N, Rüsseler M, Sterz J

[Systemic treatment of advanced prostate cancer].
Urologe A 2020; 59(12): 1565-1576;
Kretschmer A, Todenhöfer T

[The microbiome in benign prostatic hyperplasia].
Urologe A 2020; 59(10): 1204-1207;
Magistro G, Füllhase C, Stief CG, Bschleipfer T

[The role of the microbiome in urology].
Urologe A 2020; 59(12): 1463-1471;
Magistro G, Marcon J, Eismann L, Volz Y, Stief CG

[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].
Urologe A 2020; 59(1): 65-71;
Höfner K, Hampel C, Kirschner-Hermanns R, Alloussi SH, Bauer RM, Bross S, Bschleipfer T, Goepel M, Haferkamp A, Hüsch T, Kaufmann A, Kiss G, Kranz J, Oelke M, Pannek J, Reitz A, Rutkowski M, Schäfer W, Schulte-Baukloh H, Schumacher S, Seif C, Schultz-Lampel D

Can we define reliable risk factors for anastomotic strictures following radical prostatectomy?
Urologia 2020;
Spek A, Buchner A, Khury F, Khoder W, Tritschler S, Stief C

Advanced molecular imaging in histologically verified metanephric adenoma.
Urology 2020;
Mittlmeier LM, Unterrainer M, Todica A, Clevert DA, Cyran CC, Schmoeckel E, Rodler S, Bartenstein P, Stief CG, Ilhan H, Staehler M

COVID-19 and financial toxicity in patients with renal cell carcinoma.
World J Urol 2020;
Staehler MD, Battle DJ, Bergerot CD, Pal SK, Penson DF

Comparative evaluation of tissue damage induced by ultrasound and impact dual-mode endoscopic lithotripsy versus conventional single-mode ultrasound lithotripsy.
World J Urol 2020; 38(4): 1051-1058;
Khoder W, Strittmatter F, Alghamdi A, Seitz M, Stief C, Bader MJ

Comparison of stone elimination capacity and drilling speed of endoscopic clearance lithotripsy devices.
World J Urol 2020;
Bader MJ, Eisel M, Strittmatter F, Nagele U, Stief CG, Pongratz T, Sroka R, Training and Research in Urological Surgery and Technology (T.R.U.S.T.)-Group

Contemporary role of palliative cystoprostatectomy or pelvic exenteration in advanced symptomatic prostate cancer.
World J Urol 2020;
Surcel C, Mirvald C, Tsaur I, Borgmann H, Heidegger I, Labanaris AP, Sinescu I, Tilki D, Ploussard G, Briganti A, Montorsi F, Mathieu R, Valerio M, Jinga V, Badescu D, Radavoi D, van den Bergh RCN, Gandaglia G, Kretschmer A, as part of the EAU-YAU PCa Working Party

Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis.
World J Urol 2020;
Kretschmer A, Bischoff R, Chaloupka M, Jokisch F, Westhofen T, Weinhold P, Strittmatter F, Becker A, Buchner A, Stief CG

Impact of previous transurethral prostate surgery on health-related quality of life after radical prostatectomy: Does the interval between surgeries matter?
World J Urol 2020;
Chaloupka M, Figura F, Weinhold P, Jokisch F, Westhofen T, Pfitzinger P, Bischoff R, Magistro G, Strittmatter F, Becker A, Ormanns S, Schlenker B, Buchner A, Stief CG, Kretschmer A

Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
World J Urol 2020;
Rodler S, Buchner A, Ledderose ST, Eismann L, Volz Y, Pfitzinger P, Kretschmer A, Schulz GB, Karl A, Schlenker B, Stief CG, Jokisch F

The natural course of urinalysis after urinary diversion.
World J Urol 2020;
Magistro G, Zimmermann L, Bischoff R, Westhofen T, Grimm T, Schlenker B, Stief CG, Marcon J

The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates.
World J Urol 2020;
Magistro G, Keller P, Westhofen T, Schott M, Tamalunas A, Weinhold P, Stief CG